LifeMD (LFMD) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Apr, 2026Executive summary
Annual shareholder meeting scheduled for June 12, 2026, at 12:00 p.m. EDT, accessible virtually.
Shareholders encouraged to review proxy materials online before voting.
Voting and meeting participation instructions provided, including technical support and Q&A options.
Voting matters and shareholder proposals
Election of seven directors to serve until the next annual meeting.
Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.
Approval of the Fourth Amended and Restated 2020 Equity and Incentive Plan.
Authorization for the Chairman to adjourn the meeting if necessary, including to solicit additional votes or establish a quorum.
Board recommends voting "FOR" all proposals.
Board of directors and corporate governance
Seven nominees listed for election as directors: Justin Schreiber, Dr. Joseph V. DiTrolio, Dr. Joan LaRovere, Dr. Calum MacRae, John R. Strawn Jr., Roberto Simon, and William Febbo.
Latest events from LifeMD
- AI-driven virtual care and pharmacy platform achieves rapid growth and high profitability.LFMD
Investor presentation7 May 2026 - Q1 2026 delivered record subscriber growth, 88% gross margin, and reaffirmed full-year guidance.LFMD
Q1 20266 May 2026 - Key votes include director elections, auditor ratification, and a significant equity plan amendment.LFMD
Proxy filing30 Apr 2026 - Record patient growth and revenue, with durable expansion in virtual care and pharma partnerships.LFMD
Proxy filing30 Apr 2026 - Record revenue growth, expanding margins, and strong cash position drive 2026 outlook.LFMD
Q4 20259 Mar 2026 - Telehealth revenue rose 67% year-over-year, driving profitability and strong margin expansion.LFMD
Q2 20242 Feb 2026 - Q3 revenue up 38% to $53.4M, telehealth up 65%, gross margin 91%, and strong cash flow.LFMD
Q3 20242 Feb 2026 - Record revenue and EBITDA growth in 2024 set the stage for robust 2025 expansion.LFMD
Q4 202426 Jan 2026 - Up to $150M in securities, including $53.3M at-the-market stock, to fund growth and operations.LFMD
Registration Filing16 Dec 2025